A Phase 3, Open-Label, Single-Arm Study To Assess The Safety Of Hydromorphone Hydrochloride Delivered By Intrathecal Administration
The purpose of this study is to evaluate the long-term safety of hydromorphone hydrochloride administered by intrathecal delivery.
A Controlled, Two-Arm, Parallel Group, Randomized Withdrawal Study to Assess the Safety and Efficacy of Hydromorphone Hydrochloride Delivered by Intrathecal Administration Using a Programmable Implantable Pump
The purpose of this study is to determine the safety and efficacy of hydromorphone hydrochloride by intrathecal administration using a programmable implantable pump.
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Safety study to assess the 3 mg/mL baclofen injection (intrathecal) using a programmable pump
100 项与 Piramal Critical Care Ltd. 相关的临床结果
0 项与 Piramal Critical Care Ltd. 相关的专利（医药）
100 项与 Piramal Critical Care Ltd. 相关的药物交易
100 项与 Piramal Critical Care Ltd. 相关的转化医学
